| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.43M | $4.86M | - | |
| CEO | 533.6K | $1.81M | - | |
| Other | 199.7K | $678.9K | - | |
| CFO | 194.4K | $660.9K | - | |
| Other | 78.3K | $266.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Astley-Sparke Philip | Director | Sell | 32,279 | $8.06 | $260,168.74 | -2.2% | -42.0% | - | |
| Dec 16, 2024 | Patel Sushil64 | Chief Executive Officer | Sell | 10,000 | $12.42 | $124,200.00 | -4.7% | -5.6% | -23.0% | |
| Nov 18, 2024 | Xynos Konstantinos50 | Chief Medical Officer | Sell | 7,246 | $10.78 | $78,111.88 | -6.2% | +30.3% | -18.8% | |
| Nov 18, 2024 | Sarchi Christopher48 | Chief Commercial Officer | Sell | 5,207 | $10.78 | $56,131.46 | -5.6% | +30.3% | -18.8% | |
| Aug 16, 2024 | Hill Emily Luisa61 | Chief Financial Officer | Sell | 8,938 | $10.18 | $90,988.84 | -8.1% | +12.8% | -45.0% | |
| Jun 7, 2024 | Xynos Konstantinos50 | Chief Medical Officer | Sell | 15,881 | $7.50 | $119,107.50 | -11.9% | +35.7% | +31.4% | |
| May 16, 2024 | Sarchi Christopher48 | Chief Commercial Officer | Sell | 2,218 | $6.47 | $14,350.46 | -2.3% | +46.7% | +16.8% | |
| May 16, 2024 | Schwendenman Andrew | Chief Accounting Officer | Sell | 2,298 | $6.47 | $14,868.06 | -5.7% | +46.7% | +16.8% | |
| May 16, 2024 | Love Colin72 | Chief Operating Officer | Sell | 17,615 | $6.47 | $113,969.05 | -2.2% | +46.7% | +16.8% | |
| May 16, 2024 | Astley-Sparke Philip | Executive Chairman | Sell | 37,928 | $6.47 | $245,394.16 | -2.5% | +46.7% | +16.8% |